INTRODUCTION
Lacrimal gland fossa lesions represent 10% of orbital space-occupying lesions and may be divided into three categories: inflammatory, lymphoproliferative, and epithelial lesions (1) . Epithelial tumors constitute about one third of lacrimal gland fossa lesions (1) . The most common epithelial lacrimal gland tumors are pleomorphic adenoma, adenoid cystic carcinoma and not otherwise specified adenocarcinoma (1) . Distinct subtypes of lacrimal gland adenocarcinoma such as primary ductal adenocarcinoma have been recently reported in the literature (2) (3) (4) (5) (6) (7) (8) . The purpose of this case report was to describe the clinical and pathologic findings of a patient with primary ductal adenocarcinoma of the lacrimal gland.
CASE REPORT
A 78-year-old man had double vision, painless palpable mass under the right superolateral orbital rim, downward displacement and restricted adduction of the right eye. His visual acuity was 20/50 OD and 20/20 OS. Hertel exophthalmometry was 21 mm OD and 17 mm OS. Computed tomographic scans showed an infiltrative orbital mass with ill-defined, irregular margins involving the lacrimal gland and the lateral rectus muscle. Differential diagnosis inclu ded chronic inflammatory diseases, lymphoproliferative lesions and la crimal gland tumors. The patient underwent an anterior transcutaneous transseptal orbitotomy with incisional biopsy and surgical debulking. Intraoperativelly, an ill-defined mass with infiltration of the lacrimal gland and the lateral rectus muscle was observed. Histopathologic examination revealed primary ductal adenocarcinoma carcinoma of the lacrimal gland. Following the metastatic work up (involvement of the regional lymph nodes, lungs and remote viscera was not detectable using clinical examination, ultrasonography and computed tomography), the patient underwent an eyelid-sparing orbital exenteration with subsequent fitting of a bo ne-integrated prosthesis.
Macroscopically, the mass measured 24 x 15 x 10 mm. The tumor components comprised duct-type structures with papillary and cribriform patterns, surrounded by prominent basement membrane
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DISCUSSION
Primary ductal adenocarcinoma of the lacrimal gland is a highgra de neoplasm arising from the ductal epithelium. This subtype of lacrimal gland adenocarcinoma was firstly described by Katz et al. in 1996 (8) . Since then, other cases have demonstrated an aggressi ve clinical behavior and poor prognosis (3) (4) (5) 7) . Of 7 patients with primary ductal adenocarcinoma, 2 had lymph node involvement (cervical lymph nodes (4) and mediastinal lymph nodes (3) ), 4 had distant metastases (brain (5, 7) , common bile duct (5) , liver (5) , lung (5) , pancreas (5) , parotid (4) , pelvic bone (3) , skin (3) and vertebral column (3) ) and 2 died of disease (3, 5) . In the current article, the tumor cells were positive for MMP-2, MMP-9 and MMP-13. The expression of matrix metalloproteinases is unknown in primary ductal adenocarcinoma of the lacrimal gland. MMP-2 was previously associated with worse prognosis in se veral types of salivary gland carcinoma (9) . In addition, MMP-9 and MMP-13 were specifically related to poor prognosis in duct sa livary carcinoma, which is regarded as histologically and immuno histo chemically similar to primary ductal adenocarcinoma of the la crimal gland (10) . Ophthalmologists and pathologists must remember that the lacrimal gland can develop aggressive tumors, such as primary ductal adenocarcinoma. Because there are few reports of lacrimal gland ductal adenocarcinoma, its clinical behavior, prognosis and treatment are still unknown. Therefore, early recognition of this new entity may support to delineate its management.
